Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1b/2 Clinical Trial of Neoadjuvant Pembrolizumab Plus Concurrent Chemoradiotherapy With Weekly Carboplatin and Paclitaxel in Adult Patients With Resectable, Locally Advanced Adenocarcinoma of the Gastroesophageal Junction or Gastric Cardia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02730546
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:40.065136+00:00
Published At
2022-08-25T00:00:00+00:00
Record Updated At
2025-06-22
Results Posted At
2022-08-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Gastric Cardia Adenocarcinoma", "Gastroesophageal Junction Adenocarcinoma", "Stage IB Gastric Cancer AJCC v7", "Stage II Gastric Cancer AJCC v7", "Stage IIA Gastric Cancer AJCC v7", "Stage IIB Gastric Cancer AJCC v7", "Stage IIIA Gastric Cancer AJCC v7", "Stage IIIB Gastric Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-06-22"
protocolSection.identificationModule.nctId
"NCT02730546"
protocolSection.identificationModule.officialTitle
"Phase 1b/2 Clinical Trial of Neoadjuvant Pembrolizumab Plus Concurrent Chemoradiotherapy With Weekly Carboplatin and Paclitaxel in Adult Patients With Resectable, Locally Advanced Adenocarcinoma of the Gastroesophageal Junction or Gastric Cardia"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-08-25"

Study condition terms

  • Gastric Cardia Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Gastroesophageal Junction Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IB Gastric Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage II Gastric Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIA Gastric Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIB Gastric Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Gastric Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Gastric Cancer AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.